PH22654A - Substituted pyrimidine - Google Patents

Substituted pyrimidine

Info

Publication number
PH22654A
PH22654A PH29502A PH29502A PH22654A PH 22654 A PH22654 A PH 22654A PH 29502 A PH29502 A PH 29502A PH 29502 A PH29502 A PH 29502A PH 22654 A PH22654 A PH 22654A
Authority
PH
Philippines
Prior art keywords
substituted pyrimidine
pyrimidine
substituted
Prior art date
Application number
PH29502A
Other languages
English (en)
Inventor
Daluge Susan Mary
Skonezny Paul Marcel
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of PH22654A publication Critical patent/PH22654A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PH29502A 1980-11-11 1983-09-07 Substituted pyrimidine PH22654A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8036135 1980-11-11

Publications (1)

Publication Number Publication Date
PH22654A true PH22654A (en) 1988-10-28

Family

ID=10517217

Family Applications (2)

Application Number Title Priority Date Filing Date
PH29502A PH22654A (en) 1980-11-11 1983-09-07 Substituted pyrimidine
PH29503A PH25053A (en) 1980-11-11 1983-09-07 Substituted alkylbenzenes

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH29503A PH25053A (en) 1980-11-11 1983-09-07 Substituted alkylbenzenes

Country Status (35)

Country Link
US (4) US4438267A (enExample)
EP (1) EP0051879B1 (enExample)
JP (1) JPS57114581A (enExample)
KR (1) KR880001736B1 (enExample)
AR (1) AR245447A1 (enExample)
AU (1) AU549449B2 (enExample)
CA (1) CA1186310A (enExample)
CS (1) CS273153B2 (enExample)
CY (1) CY1419A (enExample)
DD (1) DD201896A5 (enExample)
DE (1) DE3173752D1 (enExample)
DK (1) DK172884B1 (enExample)
EG (1) EG16107A (enExample)
ES (5) ES8307759A1 (enExample)
FI (1) FI76333C (enExample)
GB (1) GB2087881B (enExample)
GR (1) GR81317B (enExample)
HK (1) HK23388A (enExample)
HU (1) HU188762B (enExample)
IE (1) IE52128B1 (enExample)
IL (1) IL64256A (enExample)
IT (1) IT1210589B (enExample)
MC (1) MC1418A1 (enExample)
MY (1) MY8600678A (enExample)
NO (2) NO160137C (enExample)
NZ (1) NZ198932A (enExample)
PH (2) PH22654A (enExample)
PL (4) PL139828B1 (enExample)
PT (1) PT73960B (enExample)
RU (1) RU1819264C (enExample)
SG (1) SG62686G (enExample)
SU (4) SU1424732A3 (enExample)
YU (5) YU42444B (enExample)
ZA (1) ZA817780B (enExample)
ZM (1) ZM9481A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use
DK190983A (da) * 1982-05-01 1983-11-02 Wellcome Found 2,4-diamino-5-(substituerede)pyrimidiner, fremgangsmaade til deres fremstilling og mellemprodukter derfor
US4590271A (en) * 1982-05-01 1986-05-20 Burroughs Wellcome Co. 2,4-diamino-5-(substituted)pyrimidines, useful as antimicrobials
ZA833067B (en) * 1982-05-01 1984-12-24 Wellcome Found Antibacterial compounds
US4587341A (en) * 1982-05-07 1986-05-06 Burroughs Wellcome Co. 2,4-diamino-5-(1,2,3,4-tetrahydro-(substituted or unsubstituted)-6-quinolylmethyl)pyrimidines, useful as antimicrobials
CA1244028A (en) * 1983-04-14 1988-11-01 Hans Maag Pyrimidine derivatives
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
GB8603962D0 (en) * 1986-02-18 1986-03-26 Wellcome Found Chemical compositions
LU86703A1 (fr) * 1986-12-08 1988-07-14 Oreal Composition cosmetique photostable contenant un filtre uv-a et un filtre uv-b,son utilisation pour la protection de la peau contre les rayons uv et procede de stabilisation du filtre uv-a par le filtre uv-b
FI895821A7 (fi) * 1988-12-07 1990-06-08 The Wellcome Foundation Ltd Farmaseuttisesti aktivisia CNS-yhdisteitä
GB8903978D0 (en) * 1989-02-22 1989-04-05 Coopers Animal Health Chemical compositions
GB9000241D0 (en) * 1990-01-05 1990-03-07 Coopers Animal Health Pharmaceutical use
RU95113597A (ru) * 1992-12-02 1997-06-10 ФМК Корпорейшн (US) Инсектицидная композиция, способы борьбы с насекомыми
KR100224135B1 (ko) * 1993-01-28 1999-10-15 다께다 구니오 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도
US5707996A (en) * 1995-11-06 1998-01-13 Macleod Pharmaceuticals, Inc. Pharmaceutical solution and methods for preparation thereof
DE69618986T2 (de) * 1995-12-04 2002-06-20 Arpida Ag, Muenchenstein Diaminopyrimidine, diese enthaltende pharmazeutische zusammensetzungen und ihre verwendung als antibakterielle mittel
RU2141322C1 (ru) * 1997-08-12 1999-11-20 Голощапов Николай Михайлович Иммуномодулятор с антимикобактериальной активностью "изофон", способ его получения и применения
GB0016877D0 (en) * 2000-07-11 2000-08-30 Astrazeneca Ab Chemical compounds
WO2002010156A1 (en) * 2000-07-29 2002-02-07 Arpida Ag Benzofuran derivatives and their use as antibacterial agents
DK1401413T3 (da) * 2001-06-29 2007-03-26 Ab Science Anvendelse af tyrosinkinaseinhibitorer til behandling af allergiske sygdomme
EP1401415B1 (en) * 2001-06-29 2006-06-21 AB Science Use of n-phenyl-2-pyrimidine-amine derivatives for treating inflammatory diseases
CA2452368A1 (en) * 2001-06-29 2003-01-09 Ab Science New potent, selective and non toxic c-kit inhibitors
WO2003004007A2 (en) 2001-06-29 2003-01-16 Ab Science Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (ibd)
ATE401078T1 (de) * 2001-09-20 2008-08-15 Ab Science Die verwendung von c-kithemmern zur förderung des haarwuchses
US20040242601A1 (en) * 2001-09-20 2004-12-02 Alain Moussy Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
DE60225590T2 (de) * 2001-09-20 2008-09-25 Ab Science C-kithemmer zur behandlung von bakteriellen infektionen
BRPI0412425A (pt) * 2003-07-11 2006-09-05 Arpida Ag compostos, intermediários, composições farmacêuticas, uso de um ou mais compostos, e, processo para a manufatura de composições farmacêuticas
MX2007009282A (es) * 2005-02-18 2008-02-19 Arpida Ag Nuevos procesos para la preparacion de un 2h-cromeno.
JP4850912B2 (ja) * 2005-09-01 2012-01-11 エフ．ホフマン−ラ ロシュ アーゲー Ｐ２ｘ３およびｐ３ｘ２／３モジュレーターとしてのジアミノピリミジン
US20100029689A1 (en) * 2008-07-02 2010-02-04 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
US20120122819A1 (en) * 2009-06-12 2012-05-17 Socpra - Sciences Et Genie S.E.C. Guanine riboswitch binding compounds and their use as antibiotics
CN102649786B (zh) * 2011-02-28 2014-08-27 郑州福源动物药业有限公司 一种2，4-二氨基-5-(8-二甲氨基-7-甲基-5-喹啉基甲基)-2，4-(1h，3h)嘧啶的制备方法
CN103755684B (zh) * 2014-02-10 2015-09-09 青岛蔚蓝生物股份有限公司 一种巴喹普林的制备方法
KR20220016909A (ko) * 2019-06-06 2022-02-10 베이징 타이드 파마슈티컬 코퍼레이션 리미티드 P2x3 및/또는 p2x2/3 수용체 길항제, 이를 함유하는 약학적 조성물 및 이의 용도
CN110818694B (zh) * 2019-11-18 2023-04-21 上海医药工业研究院有限公司 艾拉普林中间体及其应用
WO2022217295A1 (en) * 2021-04-09 2022-10-13 The Trustees Of The University Of Pennsylvania Control of protein expression with tmp-protac compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3049544A (en) * 1962-08-14 Method for the preparation of
DE1303727B (de) 1959-09-03 1976-02-05 Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London Alpha-Arylidensubstituierte Propioni-Irile
US3956327A (en) * 1969-03-06 1976-05-11 Burroughs Wellcome Co. Method of preparing 2,4-diamino-5-benzyl pyrimidines
BE792096A (fr) * 1971-12-01 1973-05-30 Hoffmann La Roche Nouvelles benzylpyrimidines
GB1468374A (en) 1974-03-06 1977-03-23 Wellcome Found Process for preparing a pyrimidine derivative
US4039543A (en) 1974-12-24 1977-08-02 Hoffmann-La Roche Inc. Benzylpyrimidines
GB1582245A (en) * 1976-06-09 1981-01-07 Wellcome Found Benzyl cyanoacetal derivatives and their conversion to pyrimidine derivatives
DE2730467A1 (de) * 1977-07-06 1979-01-18 Basf Ag Benzylpyrimidine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4258045A (en) * 1979-11-30 1981-03-24 Merck & Co., Inc. Inhibitor of dihydrofolate reductase
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use

Also Published As

Publication number Publication date
PL139523B1 (en) 1987-01-31
PT73960A (en) 1981-12-01
PL239280A1 (en) 1983-08-01
ES521201A0 (es) 1984-06-01
EP0051879B1 (en) 1986-02-05
FI76333C (fi) 1988-10-10
JPS57114581A (en) 1982-07-16
NO160137B (no) 1988-12-05
IL64256A (en) 1988-01-31
NO1994029I1 (no) 1994-12-29
HU188762B (en) 1986-05-28
KR830007628A (ko) 1983-11-04
PH25053A (en) 1991-01-28
HK23388A (en) 1988-04-08
SU1535379A3 (ru) 1990-01-07
MC1418A1 (fr) 1982-10-18
PL139427B1 (en) 1987-01-31
EG16107A (en) 1987-10-30
PL239278A1 (en) 1983-08-01
YU198183A (en) 1984-04-30
PL233754A1 (en) 1983-08-01
RU1819264C (ru) 1993-05-30
ES8405377A1 (es) 1984-06-01
DK172884B1 (da) 1999-09-06
NO160137C (no) 1989-03-15
FI76333B (fi) 1988-06-30
IE812631L (en) 1982-05-11
IE52128B1 (en) 1987-06-24
IL64256A0 (en) 1982-02-28
ES521204A0 (es) 1984-06-01
CS825781A2 (en) 1990-07-12
US4761475A (en) 1988-08-02
PL239279A1 (en) 1983-08-01
YU43551B (en) 1989-08-31
YU46697B (sh) 1994-04-05
US4603136A (en) 1986-07-29
EP0051879A2 (en) 1982-05-19
ES506969A0 (es) 1983-07-01
PL139827B1 (en) 1987-02-28
ZM9481A1 (en) 1983-11-21
AR245447A1 (es) 1994-01-31
PT73960B (en) 1983-11-23
IT1210589B (it) 1989-09-14
EP0051879A3 (en) 1982-08-04
DE3173752D1 (en) 1986-03-20
SU1424732A3 (ru) 1988-09-15
AU549449B2 (en) 1986-01-30
DD201896A5 (de) 1983-08-17
NO813804L (no) 1982-05-12
FI813546L (fi) 1982-05-12
MY8600678A (en) 1986-12-31
KR880001736B1 (ko) 1988-09-10
YU198383A (en) 1984-04-30
GB2087881B (en) 1985-05-15
CS273153B2 (en) 1991-03-12
YU266381A (en) 1984-04-30
GB2087881A (en) 1982-06-03
ZA817780B (en) 1983-06-29
PL139828B1 (en) 1987-02-28
SU1318148A3 (ru) 1987-06-15
ES8405378A1 (es) 1984-06-01
ES8307759A1 (es) 1983-07-01
CY1419A (en) 1988-04-22
GR81317B (enExample) 1984-12-11
ES521203A0 (es) 1984-06-01
JPH0474351B2 (enExample) 1992-11-26
NZ198932A (en) 1985-05-31
AU7733481A (en) 1982-05-20
CA1186310A (en) 1985-04-30
ES8405379A1 (es) 1984-06-01
ES8405380A1 (es) 1984-06-01
YU198283A (en) 1984-04-30
YU42444B (en) 1988-08-31
US4438267A (en) 1984-03-20
DK496681A (da) 1982-05-12
YU144288A (en) 1990-04-30
SG62686G (en) 1987-03-27
ES521202A0 (es) 1984-06-01
US4587342A (en) 1986-05-06
IT8149676A0 (it) 1981-11-10
SU1306473A3 (ru) 1987-04-23

Similar Documents

Publication Publication Date Title
PH22654A (en) Substituted pyrimidine
MY8700562A (en) Pyrimidones
JPS5795965A (en) Disubstituted pyrimidines
PH17948A (en) Pyrimidone derivatives
ZA814162B (en) Pyrimidine derivatives
EG15900A (en) Pyrimidine derivatives
GB2089792B (en) Substituted benzopyranotriazoles
JPS57123170A (en) Novel pyrimidone compound
GB2078222B (en) 4-(3-iodopropargyloxy)pyrimidines
GB2086386B (en) Pyrimidine derivatives
CS193681A1 (en) Dalkove ovladany regulacni sroub barvicich zarizeni v zasobnicich barev tiskovych stroju
GB2102800B (en) Pyrimidines
CS12981A2 (en) Zpusob pripravy benzenaminove slouceniny
CS54481A1 (en) Kapalinovy hasici pristroj
CS512381A2 (en) Pohon listu kruhoveho tkaciho stroje
JPS56159443A (en) Construction
BG30674A1 (en) Polysubstituated fluorcontaining pyrimidine
IL75635A0 (en) Substituted pyrimidine derivatives
ZW25081A1 (en) Birckwork construction
IE800710L (en) Pyrimidine derivatives
CS144381A1 (en) Zesilovac vykonu
CS560381A1 (en) Zpusob prenosu cislicovych informaci pomoci televizniho signalu
ZW9482A1 (en) Substituted pyrimidines
IE801689L (en) Substituted trichloropropylureas
JPS56154482A (en) Pyrimidone derivative